AdvanDx's Series B - II Round

AdvanDx raised a round of funding on April 08, 2014.

AdvanDx is a provider of rapid and accurate molecular diagnostic tests for identification of pathogens that cause critical infections in hospitalized patients. The company's mission is to improve anti…

Articles about AdvanDx's Series B - II Round: